Stroke
📧 Sign up to get email alerts when something new happens for Stroke.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-11-05Clinical Trial Update: SPiRE Maestro Hand Exoskeleton for Rehabilitation Post Stroke [NA]
The SPiRE Maestro Hand Exoskeleton trial for stroke rehabilitation sponsored by the VA has been withdrawn from ClinicalTrials.gov.
-
CLINICAL_TRIALS withdrawal · 2024-10-18Clinical Trial Update: High Vs Low Intensity Virtual Reality Gait Training in Individuals with Chronic Stroke [NA]
A clinical trial comparing high- versus low-intensity virtual reality gait training in individuals with chronic stroke has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-10-08Clinical Trial Update: Usability Testing of a Bilateral Activities of Daily Exercise Robot for Stroke Therapy [NA]
A clinical trial evaluating a bilateral activities of daily living exercise robot for stroke therapy was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-10-08Clinical Trial Update: Understanding Visual Processing After Occipital Stroke
University of Rochester-sponsored clinical trial investigating visual processing after occipital stroke was withdrawn. The study addressed v…
-
CLINICAL_TRIALS withdrawal · 2024-10-02Clinical Trial Update: Inpatient Physical Activity Function Through Enhanced Participation Levels in Animal-Assisted Therapy Programs [NA]
A clinical trial evaluating inpatient physical activity function through enhanced participation in animal-assisted therapy for stroke and Pa…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2024-10-01Clinical Trial Update: Efficacy and Safety Evaluation of 3K3A-APC in Ischemic Stroke [Phase 3]
A Phase 3 clinical trial evaluating 3K3A-APC for ischemic stroke has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-09-19Clinical Trial Update: Onabotulinum Toxin A (Botox) for the Treatment of Persistent Post-Stroke and Vascular Headache [Phase 1]
A Phase 1 trial evaluating Onabotulinumtoxin A (Botox) for persistent post-stroke and vascular headache was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-09-19Clinical Trial Update: BELgian CT-perFUSion Study to Select Acute Stroke Patients for Thrombectomy [NA]
A Belgian trial evaluating CT-based perfusion fusion to select acute ischemic stroke patients for thrombectomy has been withdrawn from Clini…
-
CLINICAL_TRIALS withdrawal · 2024-08-29Clinical Trial Update: Foundations in Developing Precision Cognitive Restoration [NA]
The clinical trial 'Foundations in Developing Precision Cognitive Restoration' has been withdrawn; it was investigating cognitive restoratio…
-
CLINICAL_TRIALS withdrawal · 2024-08-27Clinical Trial Update: A Functional MRI Study: Assessing Brain Function in Post Stoke Patients [NA]
A functional MRI study to assess brain function in post-stroke patients has been withdrawn. The sponsor is NeuroGlove LLC and the conditions…
-
CLINICAL_TRIALS withdrawal · 2024-08-12Clinical Trial Update: Physiotherapy and Action-Observation Therapy: An Integrated Approach for Upper Limb Impairment in Subacute Stroke [NA]
The clinical trial NCT04560764 evaluating physiotherapy and action-observation therapy for upper limb impairment after subacute stroke has b…
-
CLINICAL_TRIALS withdrawal · 2024-08-07Clinical Trial Update: tDCS to Treat Subacute Aphasia [NA]
The clinical trial studying transcranial direct current stimulation for subacute aphasia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-06-17Clinical Trial Update: The Effect of Blood Flow Restriction Training on Lower Limb Motor Function in Stroke Patients With Hemiplegia [NA]
A clinical trial evaluating blood flow restriction training to improve lower limb motor function in stroke patients with hemiplegia has been…
-
CLINICAL_TRIALS withdrawal · 2024-06-12Clinical Trial Update: Integrated Telehealth After Stroke Care [NA]
The clinical trial on Integrated Telehealth After Stroke Care sponsored by Columbia University has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-06-04Clinical Trial Update: PLAsticity, Security and Tolerance to Intermittent Hypoxic Conditioning Following Stroke [Phase 1, Phase 2]
A Phase 1/2 clinical trial investigating intermittent hypoxic conditioning to enhance neural plasticity after ischemic stroke has been withd…
-
CLINICAL_TRIALS withdrawal · 2024-06-04Clinical Trial Update: A Stepped-wedge Cluster Randomized Controlled Trial for Evaluating an Intervention in Patients With Stroke Tailored Education in Addition to Physiotherapist Treatment [NA]
The trial NCT02681146 evaluating tailored education in addition to physiotherapist treatment for stroke has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-05-21Clinical Trial Update: TMS-EEG for Cortical Excitability [NA]
This clinical trial update indicates that NCT05472363 was withdrawn. The study aimed to assess TMS-EEG measures of cortical excitability in …
-
CLINICAL_TRIALS withdrawal · 2023-10-30Clinical Trial Update: Earlier Mobilization Post Acute Thrombolysis [Phase 3]
A Phase 3 clinical trial evaluating earlier mobilization after acute thrombolysis for stroke has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2023-10-30Clinical Trial Update: Earlier Mobilization Post Acute Thrombectomy [Phase 3]
A Phase 3 clinical trial evaluating earlier mobilization after acute thrombectomy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2023-02-16Clinical Trial Update: Intensive Blood Pressure Intervention in Stroke (IBIS) Trial [Phase 3]
Phase 3 trial IBIS (Intensive Blood Pressure Intervention in Stroke) has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-12-27Clinical Trial Update: Combining Robotic-Assisted Therapy and Pharmacotherapy in Post-Stroke Rehabilitation [Phase 4]
Phase 4 trial combining robotic-assisted therapy with pharmacotherapy for stroke rehabilitation was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-10-06Clinical Trial Update: Regenerative Stem Cell Therapy for Stroke in Europe [Phase 2, Phase 3]
A stem cell therapy trial for stroke in Europe has been withdrawn after Phase 2/3 enrollment.
-
EMA withdrawal · 2021-01-25EMA Withdrawn: Clopidogrel ratiopharm GmbH (clopidogrel) — Archie Samiel s.r.o.
EMA withdrew clopidogrel from Archie Samiel s.r.o.'s product line, with therapeutic areas including peripheral vascular diseases, acute coro…
-
EMA withdrawal · 2019-05-07EMA Application withdrawn: Canakinumab Novartis (Canakinumab) — Novartis Europharm Limited
The EMA has withdrawn the application for canakinumab by Novartis Europharm Limited for indications in acute coronary syndrome, myocardial i…
-
CLINICAL_TRIALS withdrawal · 2019-02-04Clinical Trial Update: AMPLATZER Cardiac Plug (ACP) Latin American Post Market Observational
The AMPLATZER Cardiac Plug Latin American post-market observational trial (NCT01962051) sponsored by Abbott Medical Devices has been withdra…